Hong Kong IPO disclosure precedents · 49 companies, 49 items
Goods sales or procurement transactions with entities connected to directors or controlling shareholders (e.g. a director's family company or a controlling shareholder as supplier), often continuing post-listing.
The company's explanation, the adviser's view and the page in the filing: see MattersWe have entered into certain transaction with our Controlling Shareholders' associate that will constitute our continuing connected transaction upon [REDACTED].
Summary · p. 14
We enter into transactions with our related parties from time to time. The balances with related parties are trade in nature.
Financial Information · p. 248
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors are of the view that each of the material related party transactions set out in Note 35 to the Accountants’ Report included in Appendix IA to this Document was conducted in the ordinary course of business on an arm’s length basis and with normal commercial terms between the relevant parties.
Financial Information · p. 248
During the Track Record Period, we primarily conducted related party transactions with AGH and its associates, as well as SAIC and its associates.
Financial Information · p. 262
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with the related parties during the Track Record were conducted in the normal course of business and on an arm's length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Financial Information · p. 263
During the Track Record Period, our related party transaction mainly included (i) purchase of goods from our associate; (ii) purchase of buildings from the spouse of our Controlling Shareholder; (iii) lease fees paid to our Controlling Shareholder; (iv) advance to our Controlling Shareholder; and (v) recovery of advance to our Controlling Shareholder.
Financial Information · p. 368
In respect of our purchase of goods from a related party, we made the purchases from Jiangsu Lile Packaging Technology Co., Ltd. for our inner lining for the year ended December 31, 2024 and the eight months ended August 31, 2025.
Financial Information · p. 368
The company's explanation, the adviser's view and the page in the filing: see MattersWe had an outstanding balance due from Mr. Sun, the chairman of our Board, executive Director and our Controlling Shareholder, of RMB0.7 million, RMB0.8 million and RMB0.7 million as of December 31, 2023 and 2024, and August 31, 2025, respectively, in our prepayments, other receivables and other assets.
Financial Information · p. 369
The counterparties to our related party transactions primarily comprised entities under common control or significant influence of our Controlling Shareholder, including, among others, Wolong Holding and its subsidiaries.
Financial Information · p. 231
Our directors confirmed that the related party transactions and balances during the Track Record Period were conducted on normal commercial terms or terms no less favorable to us than those available from independent third parties.
Financial Information · p. 231
The company's explanation, the adviser's view and the page in the filing: see MattersSubsequent to the disposal of this subsidiary in March 2025, we have not entered into any such transactions.
Financial Information · p. 231
We have entered into certain continuing connected transactions with Topsun Group or Mr. Yang.
Summary · p. 23
During the Track Record Period, the transaction amounts in respect of our procurement of such services and products were approximately RMB78.9 million, RMB32.1 million, RMB47.0 million and RMB20.0 million for the years ended December 31, 2022, 2023 and 2024 and the eight months ended August 31, 2025, respectively.
Summary · p. 24
The company's explanation, the adviser's view and the page in the filing: see MattersServices provided Mr. Yang’s associates and the work outsourced/allocated to Topsun Group do not involve decision-making or strategic thinking, most of them are charged based on volume and/or cost incurred.
Summary · p. 24
Our transactions with related parties during the Track Record Period mainly involve the procurement of engineering services for the Phase V Expansion Project from Changsha Hongxing Architecture Engineering Co., Ltd. (湖南紅星建設有限公司), and, to a much lesser extent, provision of frozen food storage services and trading space to and purchase of other goods and services from other related parties.
Financial Information · p. 208
We will settle all non-trade nature amounts due from and due to related parties before Listing.
Financial Information · p. 208
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors are of the view that our related party transactions during the Track Record Period were conducted in the ordinary course of business at arm's length with reference to normal commercial terms, and would not distort our track record results or make our historical results not reflective of our future performance.
Financial Information · p. 208
Apart from our Company, Dr. Zhang also held directorship and shareholding interests in Waterstone Pharmaceuticals.
Summary · p. 19
The company's explanation, the adviser's view and the page in the filing: see MattersWe have entered into certain transactions with Waterstone Pharmaceuticals which will constitute continuing connected transactions upon Listing.
Summary · p. 19
After the Closing Date of the Series A Preferred Share financing, based on the terms stipulated in the Series A Share Subscription Agreements, terms and pricing policies of these transactions entered into by JD Group for our Group or between JD Group and us were established.
Financial Information · p. 345
The logistics service fees are determined after arm’s length negotiations, and are charged based on a variety of factors including storage space taken and the weights and the delivery distances of the packages.
Financial Information · p. 346
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with related parties during the Track Record Period were conducted on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Financial Information · p. 347
During the Track Record Period, we purchased equipment and spare parts and research and development outsource service from Fujian Rovos and sold of spare parts of mechanical massage equipment to Fujian Rovos, which is ultimately controlled by Mr. Wu Jinghua, our non-executive Director and substantial shareholder, and hence such transaction constituted related party transaction.
Financial Information · p. 364
For Fujian Rovos, we primarily purchased massage equipment and spare parts and research and development outsource service, totaling RMB27.89 million for the eight months ended 31 August 2025.
Business · p. 221
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with related parties during the Track Record Period were conducted on an arm's length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Financial Information · p. 364
In April 2022, to enjoy the tax benefit in Hainan and considering that a self-owned property provides more stability than a leased property, we entered into a property purchase agreement with Hainan Zimu Online Technology Company Limited* (海南自牧網絡科技有限公司) (“Hainan Zimu”), a subsidiary of Liangkebang, to purchase from it a property for a purchase price of RMB29.0 million.
Financial Information · p. 301
As Hainan Zimu failed to release the pledge on the property and compete the registration of the transfer of real estate with the relevant PRC authority by January 31, 2023 and considering that the operation of the Group is expected to be conducted primarily within Beijing in the near future, such property purchase agreement was terminated on February 6, 2023 with the consideration amount and liquidated damages, which equal to 5% of the consideration amount, transferred to the Group in 2023.
Financial Information · p. 301
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with related parties during the Track Record Period were conducted on an arm’s length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Financial Information · p. 301
We have rendered engineering solution services to Toyota in exchange for service fees of US$4.2 million in 2022, US$0.6 million in 2023, US$0.1 million in 2024 and US$11 thousand in the six months ended June 30, 2025, while no such revenues were generated in the six months ended June 30, 2024 from Toyota.
Financial Information · p. 555
We offered Virtual Driver operation services to Sinotrans in exchange for services fees of approximately US$21.2 million in 2022, US$22.5 million in 2023 and US$30.7 million in 2024, and US$12.3 million and US$11.1 million for the six months ended June 30, 2024 and 2025, respectively.
Financial Information · p. 555
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors are of the view that each of the related party transactions set out in Note 15 to the Accountants’ Report included in Appendix I to this Prospectus was conducted in the ordinary course of business on an arm’s length basis and with normal commercial terms between the relevant parties.
Financial Information · p. 557
For the year ended December 31, 2024 and the five months ended May 31, 2025, we sold certain robots and functional kits amounting to RMB0.1 million and RMB0.4 million, respectively, to a distributor of ours, namely, Wuhan Zhongtian Huatuo Intelligent Technology Co., Ltd. (武漢中天華拓智能科技有限公司), an associate of Ms. Zhi.
Financial Information · p. 476
We do not intend to enter into any new transaction agreements with such entity upon Listing.
Financial Information · p. 476
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with related parties during the Track Record Period disclosed above (i) were conducted on arm’s length basis; and (ii) do not distort our Track Record Period results or make our historical results not reflective of future performance.
Financial Information · p. 476
For the years ended December 31, 2022, 2023 and 2024, our purchases of goods from Nanjing Pharmaceutical Hubei Co., Ltd. amounted to RMB1.2 million, RMB1.3 million and RMB1.5 million, respectively.
Financial Information · p. 365
For the years ended December 31, 2022, 2023 and 2024, our rental payments for leases from Zhongshan Medical Investment amounted to RMB0.3 million, RMB0.3 million and RMB0.5 million, respectively.
Financial Information · p. 365
The company's explanation, the adviser's view and the page in the filing: see MattersAs of December 31, 2022, 2023 and 2024, we had non-trade dividends payable due to Zhongshan Medical Investment of nil, nil and RMB19.4 million, respectively, representing the dividends payable by us under our 2023 annual profit distribution plan.
Financial Information · p. 365
As of December 31, 2023 and 2024, the balance with PharmaBlock Sciences (Nanjing), Inc. represented the unsettled research and development expenses, which was trade in nature.
Financial Information · p. 487
It is the view of our Directors that each of the above transactions during the Track Record Period (i) was conducted in the ordinary course of business and on an arm’s length basis and on normal commercial terms between the relevant parties, and (ii) did not distort our results of operations over the Track Record Period or made our historical results over the Track Record Period not reflective of our expectations for our future performance.
Financial Information · p. 487
The company's explanation, the adviser's view and the page in the filing: see MattersAs of the Latest Practicable Date, to the best of our Company’s knowledge, except for PharmaBlock, they are all Independent Third Parties.
Business · p. 380
During the Track Record Period, we purchased investigational medicinal products as well as R&D services primarily from our related parties, and entered into agreements, in accordance with published prices and conditions agreed by us and the related parties.
Financial Information · p. 453
Our amount advanced to a related party, as non-current asset and of trade nature, increased from nil as of December 31, 2022 to RMB39.2 million as of December 31, 2023 and remained the same as of September 30, 2024, as we made a payment of RMB39.2 million to Ascendis Pharma for relevant drug products in November 2023 pursuant to the Commercial Supply Agreement entered in October 2023.
Financial Information · p. 444
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors confirm that our related party transactions during the Track Record Period were conducted on an arm's length basis, and that such transactions, in the aggregate, would not distort the results of operations over the Track Record Period or make the historical results over the Track Record Period not reflective of our expectations for future performance.
Financial Information · p. 455
In 2021, 2022 and 2023 and for the six months ended June 30, 2024, the amount of purchase from Daide Power Machinery was RMB52.1 million, RMB14.7 million, nil and nil, respectively.
Financial Information · p. 355
Such centralized procurement arrangement was terminated in 2023.
Business · p. 243
The company's explanation, the adviser's view and the page in the filing: see MattersThe termination of such centralized procurement arrangement has no impact on our financial and operational performance.
Business · p. 243
We have entered into a number of non-exempt continuing connected transactions with iFlytek, including: (i) Services and Products Procurement Framework Agreement, (ii) Products Provision Framework Agreement, and (iii) Bidding Cooperation Agreement.
Summary · p. 20
The company's explanation, the adviser's view and the page in the filing: see MattersOur Directors believe that our transactions with related parties during the Track Record Period were conducted on an arm’s-length basis, and they did not distort our results of operations or make our historical results not reflective of our future performance.
Financial Information · p. 462
As of December 31, 2021, 2022 and 2023 and June 30, 2024, the total amount of transactions with related parties was RMB55.0 million, RMB27.6 million, RMB33.5 million and RMB8.1 million, respectively, and total outstanding balances of our transactions with related parties was RMB7.3 million, RMB8.7 million, RMB5.8 million and RMB6.7 million, respectively.
Financial Information · p. 483
All the amounts of non-trade nature receivables due from related parties and payables due to related parties as of June 30, 2024 will be fully settled prior to Listing.
Financial Information · p. 483
The company's explanation, the adviser's view and the page in the filing: see MattersAmounts due from related parties mainly include loans made to Health Road (Guangzhou) Technology to support its daily operation. The amount is non-trade in nature and is expected to be settled before Listing.
Financial Information · p. 468
For successful purchase of insurance products by insurance clients, we paid referral fees of RMB3.9 million, RMB3.4 million and RMB1.0 million to them for FY2021, FY2022 and FY2023, respectively, representing approximately 12.2%, 6.8% and 1.5% of the total referral fees to all of our strategic channel partners for the corresponding years, respectively.
Financial Information · p. 369
The average referral fees paid to each of these companies ranged from 18.7% to 46.4% during the Track Record Period, which were on normal commercial terms or on terms no more favourable than those provided to other independent strategic channel partners during the Track Record Period.
Financial Information · p. 369
The company's explanation, the adviser's view and the page in the filing: see Matters(1) Such amounts represent the deposit with Haier Finance and Haier Consumer Finance as at the respective dates.
Financial Information · p. 371